...
首页> 外文期刊>European journal of gynaecological oncology >Alveolar rhabdomyosarcoma originating from the uterine cervix.
【24h】

Alveolar rhabdomyosarcoma originating from the uterine cervix.

机译:起源于子宫颈的肺泡横纹肌肉瘤。

获取原文
获取原文并翻译 | 示例
           

摘要

Cervical alveolar rhabdomyosarcoma is a rare condition associated with poor prognosis. An 18-year-old patient presented with vaginal bleeding and a protruding mass from the vagina. Biopsy of the mass revealed alveoler rhabdomyosarcoma (ARMS), and radiological evaluation demonstrated that it originated from the uterine cervix. First, Wertheim's operation was carried out followed by four cycles of vincristine, actinomycine-D, ifosfamide (VAI) chemotherapy. However, the disease relapsed within three months, and the patient died of disease progression. Despite combination treatment, we could not achieve a desirable survival advantage in ARMS. Future studies may unveil the genomic profile of this rare condition, leading to invention of targeted therapies, which is the emerging trend in the treatment of sarcomas.
机译:宫颈肺泡横纹肌肉瘤是一种罕见的疾病,与预后不良有关。一名18岁患者出现阴道流血并从阴道突出肿块。肿块的活检显示为肺泡横纹肌肉瘤(ARMS),放射学评估表明其起源于子宫颈。首先,进行了Wertheim手术,然后进行了四个周期的长春新碱,放线菌素-D,异环磷酰胺(VAI)化疗。但是,疾病在三个月内复发,患者死于疾病进展。尽管进行了联合治疗,我们仍无法在ARMS中获得理想的生存优势。未来的研究可能会揭示这种罕见疾病的基因组特征,从而导致靶向疗法的发明,这是肉瘤治疗的新兴趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号